Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Journal of the American College of Cardiology

• Publication date

  1992-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0735-1097(92)90010-KPMID 1512335
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dependence of recovery of contractile function on maintenance of oxidative metabolism after myocardial infarction.

  1992cited by this paper
• Quantitative Assessment of Prolonged Metabolic Abnormalities in Reperfused Canine Myocardium

  1992cited by this paper
• Parametric images of myocardial metabolic rate of glucose generated from dynamic cardiac PET and 2-[18F]fluoro-2-deoxy-d-glucose studies.

  1991cited by this paper
• Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans.

  1991cited by this paper
• Quantitative evaluation of regional substrate metabolism in the human heart by positron emission tomography.

  1991cited by this paper
• Myocardial viability--what is the definition?

  1991cited by this paper
• Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans.

  1990cited by this paper
• Validation of [1-11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium.

  1990cited by this paper
• Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose.

  1989cited by this paper
• Assessment of myocardial oxidative metabolic reserve with positron emission tomography and carbon-11 acetate.

  1989cited by this paper
• Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization.

  1989cited by this paper
• Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

  1989cited by this paper
• Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting.

  1989cited by this paper
• Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography.

  1989cited by this paper
• Measurement of absolute myocardial blood flow with H215O and dynamic positron-emission tomography. Strategy for quantification in relation to the partial-volume effect.

  1988cited by this paper
• Delineation of impaired regional myocardial perfusion by positron emission tomography with H2(15)O.

  1988cited by this paper
• Delineation of myocardial oxygen utilization with carbon-11-labeled acetate.

  1987cited by this paper
• Reversibility of cardiac wall-motion abnormalities predicted by positron tomography.

  1986cited by this paper
• Energy metabolism in reperfused heart muscle: metabolic correlates to return of function.

  1985cited by this paper
• Characterization of the functional significance of subcritical coronary stenoses with H(2)15O and positron-emission tomography.

  1985cited by this paper
• Impaired thickening of nonischemic myocardium during acute regional ischemia in the dog.

  1985cited by this paper
• Quantification of regional myocardial blood flow in vivo with H215O.

  1984cited by this paper
• Automated Correction of Patient Motion and Gray Values Prior to Subtraction in Digitized Angiography

  1984cited by this paper
• Super PETT I: A Positron Emission Tomograph Utilizing Photon Time-of-Flight Information

  1983cited by this paper
• Identification and Differentiation of Resting Myocardial Ischemia and Infarction in Man with Positron Computed Tomography, 18F‐labeled Fluorodeoxyglucose and N‐13 Ammonia

  1983cited by this paper
• Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism.

  1982cited by this paper
• Control of myocardial oxygen consumption: relative influence of contractile state and tension development.

  1968cited by this paper
• Hemodynamic determinants of oxygen consumption of the heart with special reference to the tension-time index.

  1957cited by this paper

• Quantification of myocardial oxygen extraction fraction on noncontrast MRI enabled by deep learning

  2024cites this paper
• Can C-11 Acetate PET Be a Feasible Option for Assessing Non-Culprit Lesion in STEMI Patients?

  2022cites this paper
• Imaging Cardiac Metabolism

  2021cites this paper
• Congestive Heart Failure

  2021cites this paper
• Cardiovascular Magnetic Resonance Assessment of Myocardial Oxygenation

  2019cites this paper
• Gated metabolic myocardial imaging, a surrogate for dual perfusion-metabolism imaging by positron emission tomography

  2017cites this paper
• Myocardial imaging using advanced applications of computed tomography and magnetic resonance imaging.

  2016cites this paper
• Imaging of the myocardium using (18)F-FDG-PET/MRI.

  2016cites this paper
• Evaluation of ECG-gated [11C]acetate PET for measuring left ventricular volumes, mass, and myocardial external efficiency

  2016cites this paper
• Assessment of myocardial oxygenation with MRI.

  2013influential citation
• PET in Cardiovascular Diseases

  2013cites this paper
• Current and future clinical applications of cardiac positron emission tomography.

  2013cites this paper
• Imaging of Myocardial Oxidative Metabolism in Heart Failure

  2013cites this paper
• BOLD new directions in myocardial ischemia imaging-myocardial oxygenation assessment by cardiac magnetic resonance.

  2012cites this paper
• Quantifying Myocardial Oxygenation with Cardiac Magnetic Resonance Imaging

  2012cites this paper
• Targeted metabolic imaging to improve the management of heart disease.

  2012cites this paper
• Could 13C MRI assist clinical decision‐making for patients with heart disease?

  2011cites this paper
• The Role of Cardiac PET in Translating Basic Science into the Clinical Arena

  2011cites this paper
• CHAPTER 42 – Magnetic Resonance Assessment of Myocardial Oxygenation

  2010cites this paper
• Contemporary Reviews in Cardiovascular Medicine

  2010cites this paper
• Imaging for Viable and Ischemic Myocardium

  2009cites this paper
• Proteomic analysis identifies mitochondrial metabolic enzymes as major discriminators between different stages of the failing human myocardium

  2009cites this paper
• Imaging for Viable and Ischemic Myocardium Value of Assessment of Viable and Ischemic Myocardium and Techniques Such as MRI, Radionuclide Imaging

  2009cites this paper
• Cardiac PET Imaging: Current Status and Limitations

  2009cites this paper
• Congenital Anomalies of the Coronary Arteries

  2009cites this paper
• Viable myocardium scintigraphy with intravenous nitroglycerine by computed tomography with Tc-99m (MIBI).

  2008cites this paper
• Insuficiencia cardíaca avanzada: El valor de la detección de miocardio viable a través de técnicas que evalúan el metabolismo celular

  2008cites this paper
• Feasibility study of myocardial perfusion and oxygenation by noncontrast MRI: comparison with PET study in a canine model.

  2008cites this paper
• Myocardial viability testing in patients with severe left ventricular dysfunction by SPECT and PET.

  2008influential citation
• Pulmonary hypertension secondary to coronary-to-pulmonary artery fistula.

  2008cites this paper
• Myocardial Energetics and Efficiency: Current Status of the Noninvasive Approach

  2007cites this paper
• Metabolic imaging using PET

  2007cites this paper
• Imaging myocardial metabolism.

  2007cites this paper
• Myocardial Viability Assessment with PET and PET/CT

  2007cites this paper
• Mechanisms leading to reversible mechanical dysfunction in severe CAD: alternatives to myocardial stunning.

  2006cites this paper
• Nuclear probes for assessing myocardial viability in heart failure.

  2006cites this paper
• LBBB: Challenging Our Concept of Metabolic Heart Imaging with Fluorine-18-FDG and PET?

  2006cites this paper
• Role of F‐18 FDG Positron Emission Tomography (PET) in the Assessment of Myocardial Viability

  2005cites this paper
• Assessment of myocardial viability.

  2005cites this paper
• [Relationships between changes of coronary blood flow, energy metabolism of the myocardium, and hyperinsulinemia in patients with ischemic heart disease].

  2005cites this paper
• Reduced oxidative metabolic response in dysfunctional myocardium with preserved glucose metabolism but with impaired contractile reserve.

  2004cites this paper
• Positron Emission Tomography of the Heart: Methodology, Findings in the Normal and the Diseased Heart, and Clinical Applications

  2004cites this paper
• SPECT and PET Techniques

  2003cites this paper
• Aldose reductase: a novel target for cardioprotective interventions.

  2003cites this paper
• Myocardial viability assessment using nuclear imaging

  2003cites this paper
• Robotic preparation of Sodium Acetate C 11 Injection for use in clinical PET.

  2002cites this paper
• Energy stores and metabolites in chronic reversibly and irreversibly dysfunctional myocardium in humans.

  2001cites this paper
• Measurement of myocardial blood flow with PET using 1-11C-acetate.

  2001cites this paper
• Cardiac Allograft Rejection

  2001cites this paper
• Targets for Radionuclide Imaging of Cardiac Allograft Rejection

  2001cites this paper
• Myocardium at Risk and Viable Myocardium

  2001cites this paper
• Isotopic Diagnosis of Viable Myocardium

  2001cites this paper
• Carbon-11 acetate as a tracer of myocardial oxygen consumption

  2001cites this paper
• Current status and future of metabolic cardiac imaging.

  2001cites this paper
• The pathophysiology of myocardial hibernation: current controversies and future directions.

  2001cites this paper
• Use of [11C]acetate and [15O]O2 PET for the assessment of myocardial oxygen utilization in patients with chronic myocardial infarction

  2001cites this paper
• Repetitive stunning, hibernation, and heart failure: contribution of PET to establishing a link.

  2001cites this paper
• Sublingual Nitrate-Augmented Redistribution in Thallium-201 Myocardial Perfusion SPECT Compared with Repeated Injection to Detect Viable Myocardium

  2000cites this paper
• Use of carbon 11-acetate for the measurement of myocardial oxygen consumption

  2000cites this paper
• Regional myocardial oxygen consumption estimated by carbon-11 acetate and positron emission tomography before and after repetitive ischemia

  2000cites this paper
• Hibernating and stunned myocardium: Pathophysiological considerations

  2000cites this paper
• Cardiología nuclear: bases técnicas y aplicaciones clínicas*

  2000cites this paper
• Noninvasive characterization of stunned, hibernating, remodeled and nonviable myocardium in ischemic cardiomyopathy.

  2000cites this paper
• Assessment of myocardial viability with positron emission tomography

  2000cites this paper
• [Nuclear cardiology: technical bases and clinical applications].

  2000cites this paper
• Update on nuclear medicine.

  2000cites this paper
• Feasibility of planar myocardial carbon 11-acetate imaging

  2000cites this paper
• Dobutamine-stress electrocardiographically gated positron emission tomography for detection of viable but dysfunctional myocardium

  1999cites this paper
• Pathophysiology of myocardial hibernation. Implications for the use of dobutamine echocardiography to identify myocardial viability

  1999cites this paper
• A reverse flow-metabolism mismatch pattern on PET is related to multivessel disease in patients with acute myocardial infarction.

  1999cites this paper
• Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction.

  1999cites this paper
• Nuclear Imaging Techniques for the Evaluation of TMLR

  1999cites this paper
• Assessment of myocardial response to pharmacologic interventions using an improved MR imaging technique to estimate T2 values.

  1999cites this paper
• Guías de actuación clínica de la Sociedad Española de Cardiología. Cardiología nuclear: bases técnicas y aplicaciones clínicas

  1999cites this paper
• WERTIGKEIT DER POSITRONEN-EMISSIONS- TOMOGRAPHIE MIT 18 F-FLUORODEOXYGLUKOSE BEI

  1999cites this paper
• [The clinical management guidelines of the Sociedad Española de Cardiología. Nuclear cardiology: the technical bases and clinical applications].

  1999cites this paper
• Evaluation of hibernating myocardium in patients with ischemic heart disease.

  1998cites this paper
• [Myocardial viability. Study of viability by myocardial scintigraphy].

  1998cites this paper
• Metabolic and Mitochondrial Changes in the Failure Condition of Myocardial Hibernation: Present Understanding, Existing Controversies, and Future Genetic Approaches

  1998cites this paper
• Hibernating myocardium.

  1998cites this paper
• Assessment of tissue viability: clinical demand and problems.

  1998cites this paper
• Thallium scintigraphy compared with 18F-fluorodeoxyglucose positron emission tomography for assessing myocardial viability in patients with moderate versus severe left ventricular dysfunction.

  1998cites this paper
• Detection of Viability of Dysfunctional Myocardium in Coronary Heart Disease. I. Radionuclide Imaging

  1998cites this paper
• Nuclear Imaging of the Chest

  1998cites this paper
• Coronary revascularization in the treatment of moderate and severe postischemic left ventricular dysfunction.

  1998cites this paper
• Myocardial Hibernation: Blood Flow and Metabolism

  1998cites this paper
• Prevalence of hibernating myocardium in patients with severely impaired ischaemic left ventricles

  1998cites this paper
• Cardiac positron emission tomography.

  1998cites this paper
• Predicting improved function after myocardial revascularization.

  1998cites this paper
• Assessment of Myocardial Perfusion and Metabolism: Promises and Limitations

  1998cites this paper
• LBBB: challenging our concept of metabolic heart imaging with fluorine-18-FDG and PET?

  1998cites this paper
• The usefulness of positron emission tomography.

  1998cites this paper
• Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop.

  1998cites this paper
• Expert Answers to Three Key Questions

  1997cites this paper
• Fatty acid uptake is preserved in chronically dysfunctional but viable myocardium.

  1997cites this paper
• Chronic myocardial hibernation in humans. From bedside to bench.

  1997cites this paper
• Physiologic and clinical significance of myocardial blood flow quantitation: what is expected from these measurements in the clinical ward and in the physiology laboratory?

  1997cites this paper
• Metabolic imaging using F18-fluorodeoxyglucose to assess myocardial viability

  1997cites this paper
• Correlation of functional recovery with myocardial blood flow, glucose uptake, and morphologic features in patients with chronic left ventricular ischemic dysfunction undergoing coronary artery bypass grafting.

  1997cites this paper
• [Functional radionuclide imaging in cardiac failure].

  1997cites this paper